Combating pharmaceutical counterfeiting and diversion
Posted on August 19, 2013
By: Mark Davison , CEO
Blue Sphere Health Ltd
The scourge of fake drugs is showing no signs of abating. Whereas the problem used to be confined largely to “lifestyle” drugs bought through the internet or unconventional channels, we are now also seeing counterfeit versions of sophisticated injectable products intended for hospital use to tre...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
Anti-Counterfeiting, Avastin®, Blue Sphere Health Ltd, Cancer, counterfeiting, Falsified Medicines Directive, track and trace
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
